The Use of rAAV2-RB1–Mediated Gene Therapy in Retinoblastoma

Abstract excerpt

Purpose: Retinoblastoma (RB) is a life-threatening malignancy that arises from the retina and is activated upon homozygous inactivation of the tumor suppressor RB1. Gene therapy targeting RB1 is an effective strategy to treat RB. However, it is difficult to target the RB1 gene by site-specific repair, with up to 3366 gene mutation sites identified in RB1. Thus, it is necessary to construct a promising and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ocular Oncology and Treatments
• Share to Retinal Development and Disorders
• Share to Virus-based gene therapy research